Abnormal microRNA expression in the course of hematological malignancies

References

• TaylorJXiaoWAbdel-WahabODiagnosis and classification of hematologic malignancies on the basis of geneticsBlood2017130441042328600336
   PubMed Web of Science ®Google Scholar
• YaoYDaiWGenomic Instability and CancerJ Carcinog Mutagen20145100016525541596
   PubMedGoogle Scholar
• PrakashGKaurAMalhotraPCurrent role of genetics in hematologic malignanciesIndian J Hematol Blood Transfus2016321183126855503
   PubMed Web of Science ®Google Scholar
• LiXZhongHThe diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignanciesHematology201621526327126907667
   PubMed Web of Science ®Google Scholar
• SevignaniCCalinGASiracusaLDCroceCMMammalian microR-NAs: a small world for fine-tuning gene expressionMamm Genome200617318920216518686
   PubMed Web of Science ®Google Scholar
• GrendaABudzyńskiMFilipAABiogenesis of microRNAs and their role in the development and course of selected hematologic disordersPostepy Hig Med Dosw201367174185
   Web of Science ®Google Scholar
• PasquinelliAERuvkunGControl of developmental timing by micrornas and their targetsAnnu Rev Cell Dev Biol20021849551312142272
   PubMed Web of Science ®Google Scholar
• MeloSAEstellerMDysregulation of microRNAs in cancer: playing with fireFEBS Lett2011585132087209920708002
   PubMed Web of Science ®Google Scholar
• ParkerTLStroutMPChronic lymphocytic leukemia: prognostic factors and impact on treatmentDiscov Med2011115711512321356166
   PubMed Web of Science ®Google Scholar
• HallekMLeukemia: Clymphocytic. Update on diagnosis, risk stratification, and treatmentAm J Hematol2015201590446460
   Google Scholar
• HusIBojarska-JunakADmoszyńskaAZAP-70 and CD38 expression are independent prognostic factors in patients with B-cell chronic lymphocytic leukaemia and combined analysis improves their predictive valueFolia Histochem Cytobiol200846214715218519230
   PubMed Web of Science ®Google Scholar
• CalinGACroceCMGenomics of chronic lymphocytic leukemia microRNAs as new players with clinical significanceSemin Oncol200633216717316616063
   PubMed Web of Science ®Google Scholar
• AcunzoMCroceCMDownregulation of miR-15a and miR-16-1 at 13q14 in Chronic Lymphocytic LeukemiaClin Chem201662465565626908869
   PubMed Web of Science ®Google Scholar
• ZanesiNPekarskyYTrapassoFCalinGCroceCMMicroRNAs in mouse models of lymphoid malignanciesJ Nucleic Acids Investig201011840
   Google Scholar
• HanlonKRudinCEHarriesLWInvestigating the targets of MIR-15a and MIR-16-1 in patients with chronic lymphocytic leukemia (CLLPLoS One200949e716919779621
   PubMed Web of Science ®Google Scholar
• BalattiVPekarkyYCroceCMRole of microRNA in chronic lymphocytic leukemia onset and progressionJ Hematol Oncol201581225886051
   PubMed Web of Science ®Google Scholar
• HermekingHThe miR-34 family in cancer and apoptosisCell Death Differ201017219319919461653
   PubMed Web of Science ®Google Scholar
• FaticaAFaziFMicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tuneInt J Mol Sci20131410209302095324145746
   PubMed Web of Science ®Google Scholar
• AudritoVVaisittiTRossiDNicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor networkCancer Res201171134473448321565980
   PubMed Web of Science ®Google Scholar
• ShahjahaniMMohammadiaslJNorooziFMolecular basis of chronic lymphocytic leukemia diagnosis and prognosisCell Oncol201538293109
   PubMed Web of Science ®Google Scholar
• ZanetteDLRivadaviaFMolfettaGAmiRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemiaBraz J Med Biol Res200740111435144017934639
   PubMed Web of Science ®Google Scholar
• BresinACallegariED’AbundoLmiR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse modelOncotarget2015623198071981826090867
   PubMedGoogle Scholar
• VisoneRVeroneseARassentiLZmiR-181b is a biomarker of disease progression in chronic lymphocytic leukemiaBlood2011118113072307921636858
   PubMed Web of Science ®Google Scholar
• PekarskyYCroceCMIs miR-29 an oncogene or tumor suppressor in CLL?Oncotarget20101322422720936047
   PubMedGoogle Scholar
• CostineanSSandhuSKPedersenIMSrc homology 2 domain-containing inositol-5-phosphatase and CCAAT enhancer-binding protein beta are targeted by miR-155 in B cells of Emicro-MiR-155 transgenic miceBlood200911471374138219520806
   PubMed Web of Science ®Google Scholar
• SandhuSKVoliniaSCostineanSmiR-155 targets histone deacetylase 4 (HDAC4) and impairs transcriptional activity of B-cell lymphoma 6 (BCL6) in the Eµ-miR-155 transgenic mouse modelProc Natl Acad Sci U S A201210949200472005223169640
   PubMed Web of Science ®Google Scholar
• FerracinMZagattiBRizzottoLMicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemiaMol Cancer2010912320504344
   PubMed Web of Science ®Google Scholar
• VockerodtMCaderFZShannon-LoweCMurrayPEpstein-Barr virus and the origin of Hodgkin lymphomaChin J Cancer2014331259159725418190
   PubMedGoogle Scholar
• BaiMPapoudou-BaiAKitsoulisPCell cycle and apoptosis deregulation in classical Hodgkin lymphomasIn Vivo200519243945415796209
   PubMed Web of Science ®Google Scholar
• JoosSMenzCKWrobelGClassical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2Blood20029941381138711830490
   PubMed Web of Science ®Google Scholar
• Fernandez-MercadoMManterolaLLawrieCHMicroRNAs in lymphoma: regulatory role and biomarker potentialCurr Genomics201516534935827047255
   PubMed Web of Science ®Google Scholar
• CordeiroAMonzóMNavarroANon-Coding RNAs in Hodgkin lymphomaInt J Mol Sci2017186E115428555062
   PubMed Web of Science ®Google Scholar
• CuccaroABartolomeiFCupelliEGalliEGiacheliaMHohausSPrognostic factors in hodgkin lymphomaMediterr J Hematol Infect Dis201461e201405325045461
   PubMedGoogle Scholar
• NavarroADiazTMartinezARegulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphomaBlood2009114142945295119666866
   PubMed Web of Science ®Google Scholar
• van den BergAVMagalhãesLFerreira VidalAVidalAFMicroR-NAs as biomarkers of the response to treatment with ABVD scheme in Hodgkin lymphomaJ Leuk2015030416
   Google Scholar
• ZhengRLJiangYJWangXRole of microRNAs on therapy resistance in Non-Hodgkin’s lymphomaInt J Clin Exp Med20147113818383225550890
   PubMed Web of Science ®Google Scholar
• NowakowskiGSCzuczmanMSABC, GCB, and double-hit diffuse large B-cell lymphoma: does subtype make a difference in therapy selection?Am Soc Clin Oncol Educ Book201535e449e457
   Google Scholar
• KimS-WRamasamyKBouamarHLinA-PJiangDAguiarRCTMicroRNAs miR-125a and miR-125b constitutively activate the NF- B pathway by targeting the tumor necrosis factor alpha-induced protein 3 (TNFAIP3, A20Proceedings of the National Academy of Sciences20121092078657870
   PubMed Web of Science ®Google Scholar
• NiHTongRZouLSongGChoWCMicroRNAs in diffuse large B-cell lymphomaOncol Lett20161121271128026893730
   PubMed Web of Science ®Google Scholar
• HuangXShenYLiuMQuantitative proteomics reveals that miR-155 regulates the PI3K-AKT pathway in diffuse large B-cell lymphomaAm J Pathol20121811263322609116
   PubMed Web of Science ®Google Scholar
• AlencarAJMalumbresRKozloskiGAMicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOPClinical Cancer Research201117124125413521525173
   PubMed Web of Science ®Google Scholar
• RobertusJ-LHarmsGBlokzijlTSpecific expression of miR-17-5p and miR-127 in testicular and central nervous system diffuse large B-cell lymphomaModern Pathology200922454755519287466
   PubMed Web of Science ®Google Scholar
• BaraniskinAKuhnhennJSchlegelUIdentification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous systemBlood2011117113140314621200023
   PubMed Web of Science ®Google Scholar
• SorigueMSanchoJ-MCurrent prognostic and predictive factors in follicular lymphomaAnn Hematol201897220922729032510
   PubMed Web of Science ®Google Scholar
• GrahamCLebrunDPTumor suppressors in follicular lymphomaLeuk Lymphoma20155671981198825379618
   PubMed Web of Science ®Google Scholar
• LeichEOttGRosenwaldAPathologyRAPathology, pathogenesis and molecular genetics of follicular NHLBest Pract Res Clin Haematol20112429510921658611
   PubMed Web of Science ®Google Scholar
• LeichEZamoAHornHMicroRNA profiles of t(14;18)-negative follicular lymphoma support a late germinal center B-cell phenotypeBlood2011118205550555821960592
   PubMed Web of Science ®Google Scholar
• ThompsonMAEdmondsMDLiangSmiR-31 and miR-17-5p levels change during transformation of follicular lymphomaHum Pathol20165011812626997445
   PubMed Web of Science ®Google Scholar
• WangWCorrigan-CumminsMHudsonJMicroRNA profiling of follicular lymphoma identifies microRNAs related to cell proliferation and tumor responseHaematologica201297458659422102710
   PubMed Web of Science ®Google Scholar
• VogtNDaiBErdmannTBerdelWELenzGThe molecular pathogenesis of mantle cell lymphomaLeuk Lymphoma20175871530153727894215
   PubMed Web of Science ®Google Scholar
• AhmedMZhangLNomieKLamLWangMGene mutations and actionable genetic lesions in mantle cell lymphomaOncotarget2016736586385864827449094
   PubMedGoogle Scholar
• VoseJMLymphoma: Mcell. Update on diagnosis, risk-stratification, and clinical managementAm J Hematol201320138810821088
   Google Scholar
• MasamhaCPAlbrechtTRWagnerEJDiscovery and characterization of a novel CCND1/MRCK gene fusion in mantle cell lymphomaJ Hematol Oncol2016913027025456
   PubMedGoogle Scholar
• RinaldiAPorettiGKweeIConcomitant MYC and microRNA cluster miR-17-92 (C13orf25) amplification in human mantle cell lymphomaLeuk Lymphoma200748241041217325905
   PubMed Web of Science ®Google Scholar
• ZhaoJ-JLinJLwinTmicroRNA expression profile and identification of miR-29 as a prognostic marker and pathogenetic factor by targeting CDK6 in mantle cell lymphomaBlood2010115132630263920086245
   PubMed Web of Science ®Google Scholar
• MusilovaKMrazMMicroRNAs in B-cell lymphomas: how a complex biology gets more complexLeukemia20152951004101725541152
   PubMed Web of Science ®Google Scholar
• HusbySRalfkiaerUGardeCmiR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticatorBlood2015125172669267725736311
   PubMed Web of Science ®Google Scholar
• ArakawaFKimuraYYoshidaNIdentification of miR-15b as a transformation-related factor in mantle cell lymphomaInt J Oncol201648248549226676972
   PubMed Web of Science ®Google Scholar
• WeaverCJTarimanJDMultiple myeloma genomics: a systematic reviewSemin Oncol Nurs201733323725328729121
   PubMed Web of Science ®Google Scholar
• AlzrigatMPárragaAAJernberg-WiklundHEpigenetics in multiple myeloma: From mechanisms to therapySemin Cancer Biol2017579XS104430104104430109
   Google Scholar
• GabreaALeif BergsagelPMichael KuehlWDistinguishing primary and secondary translocations in multiple myelomaDNA Repair200659–101225123316829212
   PubMed Web of Science ®Google Scholar
• RoccaroAMSaccoAThompsonBMicroRNAs 15a and 16 regulate tumor proliferation in multiple myelomaBlood2009113266669668019401561
   PubMed Web of Science ®Google Scholar
• LiYZhangBLiWMiR-15a/16 regulates the growth of myeloma cells, angiogenesis and antitumor immunity by inhibiting Bcl-2, VEGF-A and IL-17 expression in multiple myelomaLeuk Res201649737927596960
   PubMed Web of Science ®Google Scholar
• BenetatosLVartholomatosGDeregulated microRNAs in multiple myelomaCancer2012118487888721837684
   PubMed Web of Science ®Google Scholar
• UnnoKZhouYZimmermanTPlataniasLCWickremaAIdentification of a novel microRNA cluster miR-193b-365 in multiple myelomaLeuk Lymphoma200950111865187119883314
   PubMed Web of Science ®Google Scholar
• JonesCIZabolotskayaMVKingAJIdentification of circulating microRNAs as diagnostic biomarkers for use in multiple myelomaBr J Cancer2012107121987199623169280
   PubMed Web of Science ®Google Scholar
• AhmadNHaiderSJagannathanSAnaissieEDriscollJJMicroRNA theragnostics for the clinical management of multiple myelomaLeukemia201428473273824714346
   PubMed Web of Science ®Google Scholar
• ChenLLiCZhangRmiR-17-92 cluster microRNAs confers tumorigenicity in multiple myelomaCancer Lett20113091627021664042
   PubMed Web of Science ®Google Scholar
• NeriPGrattonKRenLRole of mir-30e in multiple myeloma mells resistance to lenalidomide and bortezomibBlood201212032322653977
   PubMedGoogle Scholar
• ZhangLPanLXiangBPotential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myelomaOncotarget2016721308763089127129167
   PubMedGoogle Scholar
• WangXLiCJuSMyeloma cell adhesion to bone marrow stromal cells confers drug resistance by microRNA-21 up-regulationLeuk Lymphoma201152101991199821718132
   PubMed Web of Science ®Google Scholar
• RastgooNAbdiJHouJChangHRole of epigenetics-microRNA axis in drug resistance of multiple myelomaJ Hematol Oncol201710112128623912
   PubMedGoogle Scholar
• AbdiJJianHChangHRole of micro-RNAs in drug resistance of multiple myelomaOncotarget2016737607236073527494872
   PubMedGoogle Scholar
• KumarCCGenetic abnormalities and challenges in the treatment of acute myeloid leukemiaGenes Cancer2011229510721779483
   PubMedGoogle Scholar
• X-XingChenLinJQianJDysregulation of miR-124-1 predicts favorable prognosis in acute myeloid leukemiaClin Biochem2014471–2636624135052
   PubMed Web of Science ®Google Scholar
• LiYGaoLLuoXEpigenetic silencing of microRNA-193a contributes to leukemogenesis in t(8;21) acute myeloid leukemia by activating the PTEN/PI3K signal pathwayBlood2013121349950923223432
   PubMed Web of Science ®Google Scholar
• LiHXingCZhouBA regulatory circuitry between miR-193a/miR-600 and WT1 enhances leukemogenesis in acute myeloid leukemiaExp Hematol201861596829452230
   PubMed Web of Science ®Google Scholar
• LiuLRenWChenKMiR-34a promotes apoptosis and inhibits autophagy by targeting HMGB1 in acute myeloid leukemia cellsCellular Physiology and Biochemistry20174151981199228478444
   PubMedGoogle Scholar
• StarczynowskiDTKuchenbauerFArgiropoulosBIdentification of miR-145 and miR-146a as mediators of the 5q– syndrome phenotypeNat Med2010161495819898489
   PubMed Web of Science ®Google Scholar
• LiaoQWangBLiXJiangGmiRNAs in acute myeloid leukemiaOncotarget2017823666368227705921
   PubMedGoogle Scholar
• LechmanERGentnerBNgSWKSwNmiR-126 regulates distinct self-renewal outcomes in normal and malignant hematopoietic stem cellsCancer Cell201629221422826832662
   PubMed Web of Science ®Google Scholar
• LiZLuJSunMDistinct microRNA expression profiles in acute myeloid leukemia with common translocationsProceedings of the National Academy of Sciences2008105401553515540
   PubMed Web of Science ®Google Scholar
• TrinoSLamorteDCaivanoAMicroRNAs as new biomarkers for diagnosis and prognosis, and as potential therapeutic targets in acute myeloid leukemiaInt J Mol Sci2018192E46029401684
   PubMed Web of Science ®Google Scholar
• GaoX-NLinJLiY-HYhLMicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemiaOncogene201130313416342821399664
   PubMed Web of Science ®Google Scholar
• GarzonRVoliniaSLiuC-GMicroRNA signatures associated with cytogenetics and prognosis in acute myeloid leukemiaBlood200811163183318918187662
   PubMed Web of Science ®Google Scholar
• HossainMJXieLMccahanSMCharacterization of pediatric acute lymphoblastic leukemia survival patterns by age at diagnosisJ Cancer Epidemiol201420141865979925309596
   PubMedGoogle Scholar
• MarinescuCVladareanuA-MMihaiFAcute lymphocytic leukemia in adults. Pathologic features and prognosisRom J Intern Med20155313338
   Google Scholar
• LuanCYangZChenBThe functional role of microRNA in acute lymphoblastic leukemia: relevance for diagnosis, differential diagnosis, prognosis, and therapyOnco Targets Ther201582903291426508875
   PubMed Web of Science ®Google Scholar
• ZanetteDLRivadaviaFMolfettaGAmiRNA expression profiles in chronic lymphocytic and acute lymphocytic leukemiaBraz J Med Biol Res200740111435144017934639
   PubMed Web of Science ®Google Scholar
• YehC-HMolesRNicotCClinical significance of microRNAs in chronic and acute human leukemiaMol Cancer20161513727179712
   PubMedGoogle Scholar
• BhatiaSKaulDVarmaNPotential tumor suppressive function of miR-196b in B-cell lineage acute lymphoblastic leukemiaMol Cell Biochem20103401–29710620549547
   PubMed Web of Science ®Google Scholar
• FuziwaraCSKimuraETInsights into regulation of the miR-17-92 cluster of miRNAs in cancerFront Med201523464
   Google Scholar
• LitwińskaZMachalińskiBmiRNAs in chronic myeloid leukemia: small molecules, essential functionLeuk Lymphoma20175861297130527736267
   PubMed Web of Science ®Google Scholar
• TertianGAvalosMRLéonardCAdditional translocation (9;12) (p13;q24.1) in newly diagnosed chronic myeloid leukemia: complete cytogenetic remission after interferon therapyHematol Cell Ther19963832692738974791
   PubMedGoogle Scholar
• YehC-HMolesRNicotCClinical significance of microRNAs in chronic and acute human leukemiaMol Cancer20161513727179712
   PubMedGoogle Scholar
• ShibutaTHondaEShiotsuHImatinib induces demethylation of miR-203 gene: An epigenetic mechanism of anti-tumor effect of imatinibLeuk Res201337101278128623953880
   PubMed Web of Science ®Google Scholar
• di StefanoCMironeGPernaSMarfeGThe roles of microR-NAs in the pathogenesis and drug resistance of chronic myelogenous leukemia (ReviewOncol Rep201635261462426718125
   PubMed Web of Science ®Google Scholar
• VenturiniLBattmerKCastoldiMExpression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cellsBlood2007109104399440517284533
   PubMed Web of Science ®Google Scholar
• ZhuXZhaoHLinZZhangGFunctional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemiaCancer Gene Ther2015221257358026494558
   PubMed Web of Science ®Google Scholar
• ZhouMZengJWangXMiR-370 sensitizes chronic myeloid leukemia K562 cells to homoharringtonine by targeting Forkhead box M1J Transl Med201311126524148180
   PubMedGoogle Scholar
• ZhouYHeDZengJThe effects of antisense miRNA-20a alone or in combination with imatinib on K562 cell proliferationFront Pharmacol2017812728367122
   PubMed Web of Science ®Google Scholar
• Ben-AmiOPencovichNLotemJLevanonDGronerYA regulatory interplay between miR-27a and Runx1 during megakaryopoiesisProc Natl Acad Sci U S A2009106123824319114653
   PubMed Web of Science ®Google Scholar
• San José-EnérizERomán-GómezJJiménez-VelascoAMicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutationsMol Cancer200986919723306
   PubMed Web of Science ®Google Scholar
• SetijonoSRKwonHYSongSJMicrornaSSJMicroRNA, an antisense RNA, in sensing myeloid malignanciesFront Oncol2017733129441324
   PubMed Web of Science ®Google Scholar
• MerkerovaMDKrejcikZBelickovaMGenome-wide miRNA profiling in myelodysplastic syndrome with del(5q) treated with lenalidomideEur J Haematol2015951354325287904
   PubMed Web of Science ®Google Scholar
• RhyasenGWStarczynowskiDTDeregulation of microRNAs in myelodysplastic syndromeLeukemia2012261132221852786
   PubMed Web of Science ®Google Scholar
• KirimuraSKurataMNakagawaYRole of microRNA-29b in myelodysplastic syndromes during transformation to overt leukaemiaPathology201648323324127020498
   PubMed Web of Science ®Google Scholar
• KuangXChiJWangLDeregulated microRNA expression and its pathogenetic implications for myelodysplastic syndromesHematology2016211059360227357100
   PubMed Web of Science ®Google Scholar
• BorzeIScheininISiitonenSmiRNA expression profiles in myelodysplastic syndromes reveal Epstein-Barr virus miR-BART13 dysregulationLeuk Lymphoma20115281567157321649547
   PubMed Web of Science ®Google Scholar
• KimYCheongJWKimYKSerum microRNA-21 as a potential biomarker for response to hypomethylating agents in myelodysplastic syndromesPLoS One201492e8693324503739
   PubMed Web of Science ®Google Scholar
• ShikamaYCaoMOnoTReduction of c-Fos via overexpression of miR-34a results in enhancement of TNF- production by LPS in neutrophils from myelodysplastic syndrome patientsPLoS One2016118e015852727513856
   PubMed Web of Science ®Google Scholar
• IkedaKOgawaKTakeishiYThe role of HMGA2 in the proliferation and expansion of a hematopoietic cell in myeloproliferative neoplasmsFukushima J Med Sci20125829110023237864
   PubMedGoogle Scholar
• ZhanHCardozoCRazaAMicroRNAs in myeloproliferative neoplasmsBr J Haematol2013161447148323432162
   PubMed Web of Science ®Google Scholar
• PadrnosLMesaRAMyeloproliferative neoplasms: translating new discoveries into better outcomes, better quality of lifeOncology201731752152928712096
   PubMed Web of Science ®Google Scholar
• AlizadehSAziziSGSoleimaniMFarshiYKashani KhatibZThe role of microRNAs in myeloproliferative neoplasiaInt J Hematol Oncol Stem Cell Res201610317218527489593
   PubMedGoogle Scholar
• FaticaAFaziFMicroRNA-regulated pathways in hematological malignancies: how to avoid cells playing out of tuneInt J Mol Sci20131410209302095324145746
   PubMed Web of Science ®Google Scholar
• LeeYSDuttaAMicroRNAs: small but potent oncogenes or tumor suppressorsCurr Opin Investig Drugs200676560564
   PubMedGoogle Scholar
• FanZCuiHYuHMiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expressionOncogenesis20165e22327159676
   PubMed Web of Science ®Google Scholar
• CiepłuchaAJamroziakKRobakTPerspektywy zastosowania mikroRNA w leczeniu nowotworówActa Haematol Pol200738425435
   Google Scholar
• LiZZhanWWangZInhibition of PRL-3 gene expression in gastric cancer cell line SGC7901 via microRNA suppressed reduces peritoneal metastasisBiochem Biophys Res Commun2006348122923716875667
   PubMed Web of Science ®Google Scholar